Intangible capital in the pharmaceutical & chemical industry
Katherine Gleason and
Additional contact information
Katherine Gleason: University of New Orleans
No 2003-04, Working Papers from University of New Orleans, Department of Economics and Finance
We investigate whether measures of intangible capital based on advertising and R&D can explain variation in Tobin’s Q ratio for the pharmaceutical & chemical industry using data from 1982 to 2001. The study is motivated by prior literature studying this relation in other industries, recent literature investigating intangible capital in this industry, and the larger controversy about whether stock valuations have been high due to irrational investors or large investment in intangible capital. We find that our measures of intangible capital are statistically significant determinants of Tobin’s Q and explain twenty percent of the variation in our sample.
Keywords: Intangibles; Research and Development (R&D); Advertising; Chemicals; Pharmaceuticals (search for similar items in EconPapers)
JEL-codes: G10 (search for similar items in EconPapers)
References: Add references at CitEc
Citations View citations in EconPapers (2) Track citations by RSS feed
Downloads: (external link)
Our link check indicates that this URL is bad, the error code is: 500 Can't connect to louisdl.louislibraries.org:80
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:uno:wpaper:2003-04
Access Statistics for this paper
More papers in Working Papers from University of New Orleans, Department of Economics and Finance Contact information at EDIRC.
Series data maintained by Janet Murphy Crane ().